National Audit of CKD in Primary Care
|
|
- Alice Robbins
- 6 years ago
- Views:
Transcription
1 National Audit of CKD in Primary Care David C Wheeler Royal Free Campus University College London d.wheeler@ucl.ac.uk Kidney for General Physicians RCP London 24 th November 2017
2 Who looks after CKD patients (UK)? Primary Care Nephrology Other secondary care CKD CKD CKD % of total by stage Data from NHS England Donal O'Donoghue, Personal communication
3 GPs Shoulder the Burden of CKD May 11 th, 2006
4 The history of CKD in the UK 2005 Renal National Service Framework 2007 Standardisation of creatinine measurements 2007 Mandatory egfr reporting 2008 NICE CKD Guideline 2008 Quality Outcomes Framework 2010 Quality Outcomes Framework update 2014 NICE CKD Guideline updated
5 NICE CG 182 (2014): Suggested Frequency of CKD monitoring GFR Category GFR ml/min /1.73m 2 GFR Description Frequency of monitoring egfr (times per year) A1 A2 A3 G1 90 Normal or high G Mildly decreased G3a G3b Mildly to Moderately decreased Moderately to severely decreased G Severely decreased G5 <15 Kidney failure ACR Categories: A1 (normal to mildly increased) < 3 mg/mmol, A2 (moderately increased) 3-30 mg/mmol, A3 (severely increased) > 30 mg/mmol
6 The NCKDA The National Primary Care CKD Audit 3 year project funded by NHS England as part of the National Clinical Audit and Patient Outcomes Programme and by the Welsh Government Commissioned by HQIP. Delivered by a partnership between BMJ Informatica and 3 academic institutions. Electronic audit and quality improvement tool Focus on stages 3-5 CKD (reduced egfr)
7 Aims of the audit 1. Improve identification of CKD in primary care Increase number of patients coded Improve testing of at risk groups 2. Improve management of CKD not requiring specialist review Audit against NICE targets (e.g. Monitoring, BP, CV risk assessment) 3. Improve timely referral of CKD patient requiring specialist review Audit referrals through HES linkage Snapshot of referral pathways across CCGs 4. Develop QI tools to help GPs manage CKD
8 Screen shot of the audit tool dashboard coded Possibly Uncoded Possibly Miscoded egfr tested Not tested for Proteinuria egfr not tested Tested for Proteinuria
9 Screen shot of audit tool dashboard (management of CKD)
10 Audit timetable Pilot Pilot Report Round 1 (Baseline) For any practice was a QI Period between Baseline and Audit of circa 10 months Round 2 (Audit) Practice Reports CCG & National Report
11 Coverage of Audit The GPSoC (GP Systems of Choice) contract was due to change to allow free access to commercial software and provide useable data for audit.
12 Audit Demographics 990 practices provided data 817 practices submitted 2 rounds of adequate data (5.2 million adults) Corresponding to 8% of English practice population and 70% in Wales Data was extracted from those with risk factors for CKD and those with CKD totaling 2,079,101 patients Practice populations were representative in terms of age and sex for the population of England and Wales but tended to be from rural, white areas
13 Practice Performance: Coding CKD 99.8% control 95.0% control Mean
14 Improvement in coding between audit cycles Overall 4% of practices improved coding according to our criteria within 3 months.
15 Coding with CKD % of people over 18 were coded with CKD Prevalence related to coded diabetes, hypertension and CVD No link with Deprivation Index or ethnicity 11% of people with CKD code had 2 last egfr > 60 ml/min/1.73m 2 and were therefore potentially miscoded Coding rates low in those of black ethnicity because correction factor had not been used
16 CKD prevalence: Patients with last 2 egfrs < % of people over 18 were coded with CKD 67% of people with CKD were coded
17 CKD coding: Key findings Of patients with biochemical CKD: 33% did not have a GP CKD code. Patients more likely to be coded: Males Older age More severe CKD Diabetes or hypertension Statin prescription Patients without any kidney diagnosis were less likely to receive optimal care than those coded for CKD [e.g. odds ratio for meeting blood pressure target 0.78 (95% confidence interval )].
18 Practice variation egfr testing (at risk)
19 Practice variation urinary ACR testing (at risk)
20 Practice performance in percentage of people meeting blood pressure targets by target and diabetes status <140/90 mmhg, No diabetes <130/80 mmhg, No diabetes and ACR >70 mg/mmol <130/80 mmhg, Current diabetes Includes data from 900 of 910 practices 29.2% of strata-specific measures excluded with denominator <10
21 Percentage of people with coded CKD 3-5 on a statin, by age (below 65 years vs above) and diabetes
22 Practice variation in percentage of people with coded CKD with annual repeat tests of egfr by diabetes status Includes data from 872 of 910 practices. 4.2% of strata-specific measures excluded with denominator <10
23 Practice variation in percentage with coded CKD stage 3-5 who have repeat urinary ACR tests stratified by diabetes Includes data from 872 of 910 practices 4.2% strata-specific measures excluded with denominator <10
24 Are we protecting CKD patients? Flu vaccination rates Percentage of Coded CKD Patients Vaccinated Against Flu in Last Year by Age and Diabetes No Diabetes Diabetes No Diabetes Diabetes Age <= 65 Age > 65
25 How do primary care doctors in England and Wales code and manage people with chronic kidney disease? Results from the National Chronic Kidney Disease Audit Lois G Kim 1,2, Faye Cleary 1, David C Wheeler 3, Ben Caplin 3, Dorothea Nitsch 1, Sally A Hull 4 On behalf of the UK National Chronic Kidney Disease Audit (In Press Nephrology, Dialysis Transplantation)
26 Recommendations (from 1 st Report) Recommendation 1. For people at high risk of CKD, GPs should review practice to ensure that they are including both blood tests for egfr and urinary testing for albumin to creatinine ratio (ACR). Recommendation 2. GPs should review practice to improve the coding of patients with CKD. The proportion of CKD cases that were uncoded ranged between 0% to 80%. Computerised quality improvement tools, can assist GPs with appropriate coding, which in turn supports improvements in management. Recommendation 3. Having identified patients with CKD, effort should be focused on regular review, management of high blood pressure, prescribing cholesterol lowering treatments, and performing vaccinations to improve health outcomes. Whilst 75% of people with identified CKD had a flu vaccination in accordance with NICE Guidance, only 23% of people with CKD stages 4 and 5 had the recommended pneumococcus vaccination.
27 Linking primary and secondary care data What are the rates of death for people with CKD? What are the rates of unplanned hospital admission for people with CKD? For people with CKD who were admitted to hospital: What are the rates of admission for acute kidney injury (AKI) and for acute cardiovascular (CV) disease? Do these rates vary by CKD severity and coding status? Are GP referrals for people with CKD being seen by a specialist within 18 weeks?
28 Lessons form the CKD audit It is feasible to conduct an electronic audit in primary care The audit tool needs to run on all GP computer systems There is wide variation in the use of CKD 3-5 codes with under diagnosis, and misdiagnosis Blood tests seem easier to perform than urine tests Some practices do very well with 90% testing and follow up Some practices improved their coding between the 2 rounds of data extraction but the majority did not There is room for improvement in management of BP, CVD risk with statins and immunisation Primary and secondary care need to collaborate better to achieve optimal patient outcomes.
29 Virtual CKD clinic? Primary Care A 67 year old with diabetes, an egfr of 23 ml/min/1.73sq and ACR of 203 mg/mmol EMIS web Secondary Care
30 Acknowledgements Kathryn Griffith Project Board Chair and RCGP Clinical Champion Nick Wilson CKD project manager Wales Paul Myers GP and Public Health Wales Paul Wright GP Manchester Sally Hull GP London and QMUL Fiona Loud Patient Representative Richard Fluck National Kidney Director Maarten Taal Nephrologist Derby Hugh Gallagher Nephrologist St Helier Dorothea Nitsch LSHTM Andy Syme Informatica Project Manager Richard Gunn Informatica Matthew Harker BMJ Lois Kim Researcher LSHTM Fay Clearly Researcher LSHTM All the GP s and Practice Managers
"!!!#$ %&'( )" * + "!! ) *)$,! -. /.
! "!!!#$ %&'( )" * + ) "! " ) * "!! ) *)$,! -. /. -/!0-/ 1%&'& +",! 2,!* ).!+!. *3!".45!!!. ) / $.6.!.!*. +",!%!!.3 " *!!!!!!** " $" *7!!.!!! " $!! " $... " *.". 8.-8!! 8!! " ** 6!!!.!!* * )! * ) 1. Improve
More informationNational Chronic Kidney Disease Audit
National Chronic Kidney Disease Audit // National Report: Part 2 December 2017 Commissioned by: Delivered by: Analytical Team Faye Cleary, Research Assistant, London School of Hygiene and Tropical Medicine
More informationNational Chronic Kidney Disease Audit
National Chronic Kidney Disease Audit // National Report: Part 2 December 2017 Commissioned by: Delivered by: // Foreword by Fiona Loud And if, as part of good, patient-centred care, a record of your condition(s),
More informationCKD at the primary and secondary care interface. Paul Cockwell Consultant Nephrologist Clinical Service Lead Renal Medicine, QEHB
CKD at the primary and secondary care interface Paul Cockwell Consultant Nephrologist Clinical Service Lead Renal Medicine, QEHB The Health improvement Network (THIN): 6.7 million patients from 426 primary
More informationThe National Quality Standards for Chronic Kidney Disease
The National Quality Standards for Chronic Kidney Disease Dr Robert Lewis Chief of Service, Wessex Kidney Centre, Portsmouth Specialist Committee Member Quality Standard for Chronic Kidney Disease, NICE
More informationCKD and risk management : NICE guideline
CKD and risk management : NICE guideline 2008-2014 Shahed Ahmed Consultant Nephrologist shahed.ahmed@rlbuht.nhs.uk Key points : Changing parameters of CKD and NICE guidance CKD and age related change of
More informationProfessor Suetonia Palmer
Professor Suetonia Palmer Department of Medicine Nephrologist Christchurch Hospital Christchurch 14:00-14:55 WS #108: The Kidney Test - When To Test and When to Refer ( and When Not To) 15:05-16:00 WS
More informationEast London Community Kidney Service
East London Community Kidney Service Sally Hull, Neil Ashman, Sec Hoong, Nicola Thomas, Helen Rainey April 2017 Haemodialysis/million population What is the Problem? Fast rising ESRD rates in East London
More informationNational Diabetes Audit
National Diabetes Audit Executive Summary Key findings about the quality of care for people with diabetes in England and Wales Report for the audit period 2007-2008 Prepared in partnership with: Executive
More informationSERVICE SPECIFICATION 6 Conservative Management & End of Life Care
SERVICE SPECIFICATION 6 Conservative Management & End of Life Care Table of Contents Page 1 Key Messages 2 2 Introduction & Background 2 3 Relevant Guidelines & Standards 2 4 Scope of Service 3 5 Interdependencies
More informationNational Diabetes Insulin Pump Audit, England and Wales
National Diabetes Insulin Pump Audit, 2016-2017 England and Wales V0.22 7 March 2017 Prepared in collaboration with: The Healthcare Quality Improvement Partnership (HQIP). The National Diabetes Audit (NDA)
More informationNational Surveillance System for Dialysis Centre and Dialysis Associated Diseases
National Surveillance System for Dialysis Centre and Dialysis Associated Diseases Dr Richard Fluck Consultant Renal Physician & Clinical Director, Royal Derby Hospital UK RA Vascular Access Survey 2005
More informationBulletin Independent prescribing information for NHS Wales
Bulletin Independent prescribing information for NHS Wales October 2017 Chronic kidney disease Chronic kidney disease (CKD) is a long-term irreversible deterioration in the function of the kidneys, often
More informationVascular checks a vascular risk assessment and management. Heather White Deputy Branch Head Vascular Programme
Vascular checks a vascular risk assessment and management Heather White Deputy Branch Head Vascular Programme Three Questions (1) What is the starting point? (2) Where are we now? (3) What happens next?
More informationOnline clinical pathway for chronic kidney disease (CKD) in primary care. February 27, 2015 Dr. Kerry McBrien University of Calgary
Online clinical pathway for chronic kidney disease (CKD) in primary care February 27, 2015 Dr. Kerry McBrien University of Calgary FACULTY/PRESENTER DISCLOSURE Faculty: Kerry McBrien Relationships with
More informationNational Diabetes Audit, Report 1: Care Processes and Treatment Targets
National Diabetes Audit, 2016-17 Report 1: Care Processes and Treatment Targets England and Wales 14 th March 2018 Full Report Prepared in collaboration with: The Healthcare Quality Improvement Partnership
More informationNational Diabetes Audit, Report 2a: Complications and Mortality (complications of diabetes) England and Wales 13 July 2017
National Diabetes Audit, 2015-16 Report 2a: Complications and Mortality (complications of diabetes) 13 July 2017 V0.22 7 March 2017 Prepared in collaboration with: The Healthcare Quality Improvement Partnership
More informationThe Health Problem: Guidelines: NHS Priority:
PRIORITY BRIEFING The purpose of this briefing paper is to aid Stakeholders in prioritising topics to be taken further by PenCLAHRC as the basis for a specific evaluation or implementation research project.
More informationDiabetes Prevention Programme and National Diabetes Audit Pilot
Diabetes Prevention Programme and National Diabetes Audit Pilot Requirement Specification 1 Copyright 2017, Health and Social Care Information Centre Document filename: Annex A- Diabetes Prevention Programme
More informationOutcomes of diabetes care in England and Wales. A summary of findings from the National Diabetes Audit : Complications and Mortality reports
Outcomes of diabetes care in England and Wales A summary of findings from the National Diabetes Audit 2015 16: Complications and Mortality reports About this report This report is for people with diabetes
More informationCardiovascular disease profile
Cardiovascular disease profile Kidney disease Background This chapter of the Cardiovascular disease profiles focuses on kidney disease and is produced by the National Cardiovascular Intelligence Network
More informationFaculty/Presenter Disclosure
CSI for CKD Unravelling the myths surrounding chronic kidney disease Practical Evidence for Informed Practice Oct 21 2016 Dr. Scott Klarenbach University of Alberta Slide 1: Option B (Presenter with NO
More informationNational Diabetes Audit
National Diabetes Audit 2012-2013 Report 1: Care Processes and Treatment Targets Clinical Commissioning Group (CCG) / Local Health Board (LHB) Report Summary for NHS Bristol CCG (11H) Key findings about
More informationNational Diabetes Audit
National Diabetes Audit 2012-2013 Report 1: Care Processes and Treatment Targets Clinical Commissioning Group (CCG) / Local Health Board (LHB) Report Summary for NHS Wirral CCG (12F) Key findings about
More information2. Quality and Outcomes Framework: new NICE recommendations
Proposed Changes to the GMS Contract 2013/14 1. GP pay and expenses uplift It is proposed GP pay and expenses is uplifted by 1.5%. This increased investment will allow for an average pay increase of up
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Chronic kidney disease: early identification and management of adults with chronic kidney disease in primary and secondary
More informationManaging Patients with CKD in Primary Care: A Shared Care Pathway. 5 th April 2018
Managing Patients with CKD in Primary Care: A Shared Care Pathway 5 th April 2018 Learning Objectives 1) What health risks does CKD represent? 2) Why change how we manage CKD in NWL? 1) How do we improve
More informationNational Diabetes Transition Audit, England and Wales
National Diabetes Transition Audit, 2011-2017 England and Wales Prepared in collaboration with: The Healthcare Quality Improvement Partnership (HQIP). The National Diabetes Audit (NDA) is part of the National
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Urinary tract infection: diagnosis, treatment and long-term management of urinary tract infection in children 1.1 Short title
More informationNational Diabetes Audit, Report 1: Care Processes and Treatment Targets
National Diabetes Audit, 2016-17 Report 1: Care Processes and Treatment Targets England and Wales 14 th March 2018 Learning Disability - Supplementary Information Prepared in collaboration with: The Healthcare
More informationSouthern Derbyshire Shared Care Pathology Guidelines. AKI guidelines for primary care
Southern Derbyshire Shared Care Pathology Guidelines AKI guidelines for primary care Contents: Flow Diagram: Recommended response time to AKI warning stage test results for adults in primary care 2 Table
More informationEvaluation of Chronic Kidney Disease KDIGO. Paul E de Jong University Medical Center Groningen The Netherlands
Evaluation of Chronic Kidney Disease Paul E de Jong University Medical Center Groningen The Netherlands Evaluation and Management of CKD 1. Definition and classification of CKD 2. Definition and impact
More informationOffice Management of Reduced GFR Practical advice for the management of CKD
Office Management of Reduced GFR Practical advice for the management of CKD CKD Online Education CME for Primary Care April 27, 2016 Monica Beaulieu, MD FRCPC MHA CHAIR PROVINCIAL KIDNEY CARE COMMITTEE
More informationSpecialised renal services and QIPP
Specialised renal services and QIPP Contents 1. Executive summary 2. Background 2.1 QIPP 2.2 Specialised renal services 3. Main themes 3.1 Need 3.2 Diagnosis 3.3 Commissioning 3.4 Treatment 3.5 Care 4.
More informationManagement of early chronic kidney disease
Management of early chronic kidney disease GREENLANE SUMMER GP SYMPOSIUM 2018 Jonathan Hsiao Renal and General Physician Introduction A growing public health problem in NZ and throughout the world. Unknown
More informationPrimary Care Approach to Management of CKD
Primary Care Approach to Management of CKD This PowerPoint was developed through a collaboration between the National Kidney Foundation and ASCP. Copyright 2018 National Kidney Foundation and ASCP Low
More informationegfr > 50 (n = 13,916)
Saxagliptin and Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Moderate or Severe Renal Impairment: Observations from the SAVOR-TIMI 53 Trial Supplementary Table 1. Characteristics according
More informationNational Diabetes Audit
National Diabetes Audit 2012-2013 Report 1: Care Processes and Treatment Targets Report Summary for Dorset County Hospital (RBD01) Key findings about the outcomes for people with diabetes in Dorset County
More informationLondon Strategic Clinical Networks. Quality Standard. Version 1.0 (2015)
London Strategic Clinical Networks Quality Standard Version 1.0 (2015) Supporting the delivery of equitable, high quality AKI care through collaboration www.londonaki.net @LondonAKI Overview The management
More informationNice CKD Clinical Guidelines 2014 The challenges and benefits they may bring toprimary care
Nice CKD Clinical Guidelines 2014 The challenges and benefits they may bring toprimary care Paula D Souza Senior CKD Nurse Specialist Royal Devon and Exeter Healthcare Trust Introduction Background What
More informationNephrology referral - Does my patient need it? Disclosure
Nephrology referral - Does my patient need it? Sophia Chou, MD MSc March 10, 2018 Faculty: Sophia Chou Disclosure Relationships with commercial interest: None Potential conflict of interest: None 1 Objectives
More informationChronic Kidney Disease: Optimal and Coordinated Management
Chronic Kidney Disease: Optimal and Coordinated Management Michael Copland, MD, FRCPC Presented at University of British Columbia s 42nd Annual Post Graduate Review in Family Medicine Conference, Vancouver,
More informationQUICK REFERENCE FOR HEALTHCARE PROVIDERS
KEY MESSAGES 1 SCREENING CRITERIA Screen: Patients with DM and/or hypertension at least yearly. Consider screening patients with: Age >65 years old Family history of stage 5 CKD or hereditary kidney disease
More informationKidney Care. Chronic Kidney Disease in England: The Human and Financial Cost. Marion Kerr, Insight Health Economics. Better Kidney Care for All
Kidney Care Chronic Kidney Disease in England: The Human and Financial Cost Marion Kerr, Insight Health Economics Better Kidney Care for All Contents Acknowledgements...03 Abbreviations...04 Executive
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Briefing paper QOF indicator area: Primary prevention of CVD Potential output:
More informationChronic Kidney Disease. Paul Cockwell Queen Elizabeth Hospital Birmingham
Chronic Kidney Disease Paul Cockwell Queen Elizabeth Hospital Birmingham Paradigms for chronic disease 1. Acute and chronic disease is closely linked 2. Stratify risk and tailor interventions around failure
More informationCVD Prevention Optimal Value Pathway
CVD Prevention Optimal Value Pathway Miles Freeman NHS RightCare Dr Matt Kearney GP and National Clinical Director CVD Prevention 22 nd November 2016 Structure Rightcare Background Why OVP? Key elements
More informationDiabetes. Ref HSCW 024
Diabetes Ref HSCW 024 Why is it important? Diabetes is an increasingly common, life-long, progressive but largely preventable health condition affecting children and adults, causing a heavy burden on health
More informationSwindon Diabetes Guidelines: Management of Chronic Kidney Disease Associated with Diabetes Mellitus
Swindon Diabetes Guidelines: Management of Chronic Kidney Disease Associated with Diabetes Mellitus 1 Contents Executive Summary... 3 How to Screen for Diabetic Nephropathy... 4 What to Measure... 4 Frequency
More informationZhao Y Y et al. Ann Intern Med 2012;156:
Zhao Y Y et al. Ann Intern Med 2012;156:560-569 Introduction Fibrates are commonly prescribed to treat dyslipidemia An increase in serum creatinine level after use has been observed in randomized, placebocontrolled
More informationProof of Concept: NHS Wales Atlas of Variation for Cardiovascular Disease. Produced on behalf of NHS Wales and Welsh Government
Proof of Concept: NHS Wales Atlas of Variation for Cardiovascular Disease Produced on behalf of NHS Wales and Welsh Government April 2018 Table of Contents Introduction... 3 Variation in health services...
More informationCKD Conservative care and preparation for dialysis Dr Anirudh Rao Registrar, UK Renal Registry. UK Renal Registry 2013 Annual Audit Meeting
CKD Conservative care and preparation for dialysis Dr Anirudh Rao Registrar, UK Renal Registry UK Renal Registry 2013 Annual Audit Meeting Scope of the talk Background CK MAPPS EQUAL My Research Future
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE. Type 2 diabetes: the management of type 2 diabetes (update)
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Type 2 diabetes: the management of type 2 diabetes (update) 1.1 Short title Type 2 diabetes (update) 2 Background a) The National
More informationChronic kidney disease screening and assessment
Care map information Information resources for patients and carers Aboriginal and Torres Strait Islanders DEFINITION OF CKD egfr
More informationNHS Diabetes Programme
NHS Diabetes Programme London Regional Event Vision Through the NHS Diabetes Programme we will aim to slow the future growth in the incidence of diabetes and reduce the rate of complications associated
More informationHow the UK Renal Registry has improved the lives of renal patients
How the UK Renal Registry has improved the lives of renal patients [is improving and will improve] Dr Fergus Caskey Medical Director of the UK Renal Registry NKF Annual Conference, Reading, 10th October
More informationABCD and Renal Association Clinical Guidelines for Diabetic Nephropathy-CKD. Management of Dyslipidaemia and Hypertension in Adults Dr Peter Winocour
ABCD and Renal Association Clinical Guidelines for Diabetic Nephropathy-CKD. Management of Dyslipidaemia and Hypertension in Adults Dr Peter Winocour Dr Indranil Dasgupta Rationale No national practical
More informationWhy are NICE guidelines and standards important and relevant to us?
Why are NICE guidelines and standards important and relevant to us? Dr Liz England GP, Laurie Pike health centre RCGP Mental Health Clinical and Commissioning Lead SWB CCG Mental Health Lead NIHR Clinical
More informationPrescription Rates of Cardiovascular Medications in a Large UK Primary Care Chronic Kidney Disease Cohort
Prescription Rates of Cardiovascular Medications in a Large UK Primary Care Chronic Kidney Disease Cohort Rupert Major 1,2, David Shepherd 2, Graham Warwick 1, Nigel Brunskill 1,3 1 Department of Nephrology,
More informationChapter 1: CKD in the General Population
Chapter 1: CKD in the General Population Overall prevalence of CKD (Stages 1-5) in the U.S. adult general population was 14.8% in 2011-2014. CKD Stage 3 is the most prevalent (NHANES: Figure 1.2 and Table
More informationChronic Kidney Disease (CKD) and egfr: Decision and Dilemma. Dr Bhavna K Pandya Consultant Nephrologist University Hospital Aintree
Chronic Kidney Disease (CKD) and egfr: Decision and Dilemma Dr Bhavna K Pandya Consultant Nephrologist University Hospital Aintree Topics CKD background egfr background Patient with egfr Referral Guidelines
More informationPlenary presentations 1
Wessex Cardiovascular Strategic Clinical Network Acute Kidney Injury Launch Event Wednesday 15 April 2015, 10.00 16.30 Plenary presentations 1 Wessex Acute Kidney Injury Clinical Forum Dr Mark Uniacke
More informationNORTHERN IRELAND GUIDELINES FOR MANAGEMENT OF CHRONIC KIDNEY DISEASE
NORTHERN IRELAND GUIDELINES FOR MANAGEMENT OF CHRONIC KIDNEY DISEASE Practical points for use of estimated GFR + quality outcome framework indicators Developed by GAIN and the Northern Ireland Nephrology
More informationNICE offer to STPs: CVD prevention
NICE offer to STPs: CVD prevention Zoe Girdis Regional Technical Adviser South of England and Channel Islands NICE support for STPs Based on the best available evidence of what works and is costeffective,
More informationPopulation-wide Chronic Kidney Disease Management Reducing the Incidence of Kidney Failure
Population-wide Chronic Kidney Disease Management Reducing the Incidence of Kidney Failure Dr Hugh Rayner MD FRCP DipMedEd Consultant Nephrologist Heart of England NHS Foundation Trust hughrayner@nhs.net
More informationManaging Chronic Kidney Disease: Reducing Risk for CKD Progression
Managing Chronic Kidney Disease: Reducing Risk for CKD Progression Arasu Gopinath, MD Clinical Nephrologist, Medical Director, Jordan Landing Dialysis Center Objectives: Identify the most important risks
More informationCreatinine & egfr A Clinical Perspective. Suheir Assady MD, PhD Dept. of Nephrology & Hypertension RHCC
Creatinine & egfr A Clinical Perspective Suheir Assady MD, PhD Dept. of Nephrology & Hypertension RHCC CLINICAL CONDITIONS WHERE ASSESSMENT OF GFR IS IMPORTANT Stevens et al. J Am Soc Nephrol 20: 2305
More informationChronic kidney disease (CKD) (Southampton pathway)
Background information Patient information Key messages for this pathway Definitions and abbreviations used in this pathway Classification of CKD Diagnosis of CKD Summary of referral criteria Screening
More informationIdentifying and Managing Chronic Kidney Disease: A Practical Approach
Identifying and Managing Chronic Kidney Disease: A Practical Approach S. Neil Finkle, MD, FRCPC Associate Professor Division of Nephrology, Department of Medicine, Dalhousie University Program Director,
More informationNarender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York
Narender Goel et al. Middletown Medical PC, Montefiore Medical Center & Albert Einstein College of Medicine, New York 4th International Conference on Nephrology & Therapeutics September 14, 2015 Baltimore,
More informationTread Carefully Because you Tread on my Nephrons. Prescribing Hints in Renal Disease
Tread Carefully Because you Tread on my Nephrons Prescribing Hints in Renal Disease David WP Lappin,, MB PhD FRCPI Clinical Lecturer in Medicine and Consultant Nephrologist and General Physician, Merlin
More informationGetting serious about preventing cardiovascular disease
Getting serious about preventing cardiovascular disease Southwark s Experience Professor Kevin Fenton Director of Health and Wellbeing, London Borough of Southwark February 2018 Twitter: @ProfKevinFenton
More informationImproving Outcomes for People with Diabetes in Primary Care National Conference - Wednesday, 8 February 2017 Programme
Improving Outcomes for People with Diabetes in Primary Care National Conference - Wednesday, 8 February 2017 Programme Improving Outcomes for People with Diabetes in Primary Care National Conference -
More informationThe audit is managed by the Royal College of Psychiatrists in partnership with:
Background The National Audit of Dementia (NAD) care in general hospitals is commissioned by the Healthcare Quality Improvement Partnership on behalf of NHS England and the Welsh Government, as part of
More informationNational Paediatric Diabetes Audit
National Paediatric Diabetes Audit Parent and Carers Report 2015-16 Commissioned by the Healthcare Quality Improvement Partnership Managed by the Royal College of Paediatrics and Child Health National
More informationConcept and General Objectives of the Conference: Prognosis Matters. Andrew S. Levey, MD Tufts Medical Center Boston, MA
Concept and General Objectives of the Conference: Prognosis Matters Andrew S. Levey, MD Tufts Medical Center Boston, MA General Objectives Topics to discuss What are the key outcomes of CKD? What progress
More informationEffective information and learning from data the East London Approach
Effective information and learning from data the East London Approach Dr Kambiz Boomla GP and Clinical Senior Lecturer Queen Mary University of London and Clinical IT lead for east London CCGs Dr John
More informationClinical guideline Published: 23 July 2014 nice.org.uk/guidance/cg182
Chronic kidney disease in adults: assessment and management Clinical guideline Published: 23 July 2014 nice.org.uk/guidance/cg182 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationCKDinform: A PCP s Guide to CKD Detection and Delaying Progression
CKDinform: A PCP s Guide to CKD Detection and Delaying Progression Learning Objectives Describe suitable screening tools, such as GFR and ACR, for proper utilization in clinical practice related to the
More informationAcute Kidney Injury 2
South West Cardiovascular Strategic Clinical Network Acute Kidney Injury 2 Audit review meeting 18/07/2014 Redwood Education Centre Author: Summary of results: Dr Preetham Boddana Consultant Nephrologist
More informationAngiotensin Converting Enzyme inhibitor (ACEi) / Angiotensin Receptor Blocker (ARB) To STOP OR Not in Advanced Renal Disease
Angiotensin Converting Enzyme inhibitor (ACEi) / Angiotensin Receptor Blocker (ARB) To STOP OR Not in Advanced Renal Disease Investigator Meeting 12 th September 2017 - Sheffield Prof Sunil Bhandari Consultant
More information6/10/2014. Chronic Kidney Disease - General management and standard of care. Management of CKD according to stage (KDOQI 2002)
Chronic Kidney Disease - General management and standard of care Dr Nathalie Demoulin, Prof Michel Jadoul Cliniques universitaires Saint-Luc Université Catholique de Louvain What should and can be done
More informationIdentification, management and referral of adults with chronic kidney disease: concise guidelines
Identification, management and referral of adults with chronic kidney disease: concise guidelines Abstract Chronic Kidney Disease (CKD) is often thought to be a relatively rare condition requiring specialist
More informationNew indicators to be added to the NICE menu for the QOF and amendments to existing indicators
New indicators to be added to the for the QOF and amendments to existing indicators 1 st September 2015 Version 1.1 This document was originally published on 3 rd August 2015, it has since been updated.
More informationChapter 2: Identification and Care of Patients With Chronic Kidney Disease
Chapter 2: Identification and Care of Patients With Chronic Kidney Disease Introduction The examination of care in patients with chronic kidney disease (CKD) is a significant challenge, as most large datasets
More informationCKD FOR INTERNISTS. Dr Ahmed Hossain Associate professor Medicine Sir Salimullah Medical College
CKD FOR INTERNISTS Dr Ahmed Hossain Associate professor Medicine Sir Salimullah Medical College INTRODUCTION In 2002, the National Kidney Foundation s Kidney Disease Outcomes Quality Initiative(KDOQI)
More informationTREAT THE KIDNEY TO SAVE THE HEART. Leanna Tyshler, MD Chronic Kidney Disease Medical Advisor Northwest Kidney Centers February 2 nd, 2009
TREAT THE KIDNEY TO SAVE THE HEART Leanna Tyshler, MD Chronic Kidney Disease Medical Advisor Northwest Kidney Centers February 2 nd, 2009 1 ESRD Prevalent Rates in 1996 per million population December
More informationDESIGNED TO TACKLE RENAL DISEASE IN WALES DRAFT 2 nd STRATEGIC FRAMEWORK for
DESIGNED TO TACKLE RENAL DISEASE IN WALES DRAFT 2 nd STRATEGIC FRAMEWORK for 2008-11 1. Aims, Outcomes and Outputs The National Service Framework Designed to Tackle Renal Disease in Wales sets standards
More informationPOSITION STATEMENT. Diabetic eye screening April Key points
POSITION STATEMENT Title Date Diabetic eye screening April 2013 Key points Diabetic retinopathy is the most common cause of sight loss in the working age population (1) All people with any type of diabetes
More informationElevation of Serum Creatinine: When to Screen, When to Refer. Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC
Elevation of Serum Creatinine: When to Screen, When to Refer Bruce F. Culleton, MD, FRCPC; and Jolanta Karpinski, MD, FRCPC Presented at the University of Calgary s CME and Professional Development 2006-2007
More informationOutline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW. Question 1: Which of these patients has CKD?
CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,
More informationOutline. Outline CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW 7/23/2013. Question 1: Which of these patients has CKD?
CHRONIC KIDNEY DISEASE UPDATE: WHAT THE GENERALIST NEEDS TO KNOW MICHAEL G. SHLIPAK, MD, MPH CHIEF-GENERAL INTERNAL MEDICINE, SAN FRANCISCO VA MEDICAL CENTER PROFESSOR OF MEDICINE, EPIDEMIOLOGY AND BIOSTATISTICS,
More informationThe Pursuit of Prevention of Renal failure in an imperfect world-is it possible in the 21 st century?
The Pursuit of Prevention of Renal failure in an imperfect world-is it possible in the 21 st century? By: Baskar, WDHB, Renal Service Auckland New Zealand Presented at : 4 th International Conference on
More informationGOVERNING BODY REPORT
GOVERNING BODY REPORT DATE OF MEETING: 20th September 2012 TITLE OF REPORT: KEY MESSAGES: NHS West Cheshire Clinical Commissioning Group has identified heart disease as one of its six strategic clinical
More informationComposite Performance Report
Composite Performance Report 10 9 91% 8 7 65% 68% 65% 6 56% 5 4 3 2 44% 37% 48% 31% 19% 29% 1 6% Key: Report Measure Name Cohort Target Cohort Definition Formula 1 Control Blood Pressure All patients who
More informationStrategic Clinical Network for Yorkshire and the Humber
Strategic Clinical Network for Yorkshire and the Humber SCN-CVD-Nephrology-AKI John Stoves Park Plaza, Leeds 16 th June 2014 2 Strategic Clinical Networks SCNs operate as engines for change across complex
More informationSection Questions Answers
Section Questions Answers Guide to CKD Screening and Evaluation -Alec Otteman, MD Delaying Progression - Paul Drawz, MD, MHS, MS 1. Modifiable risk factors for CKD include: a. Diabetes b. Hypertension
More informationThe Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009
The Diabetes Kidney Disease Connection Missouri Foundation for Health February 26, 2009 Teresa Northcutt, RN BSN Primaris Program Manager, Prevention - CKD MO-09-01-CKD This material was prepared by Primaris,
More informationCHRONIC KIDNEY DISEASE DIAGNOSIS
CHRONIC KIDNEY DISEASE DIAGSIS GFR categories, description and range WHO SHOULD BE TESTED FOR CKD CLASSIFICATION OF CKD USING egfr AND ACR CATEGORIES Offer testing for CKD using egfr, creatinine and ACR
More informationPOTENTIAL LINKAGES BETWEEN THE QUALITY AND OUTCOMES FRAMEWORK (QOF) AND THE NHS HEALTH CHECK
POTENTIAL LINKAGES BETWEEN THE QUALITY AND OUTCOMES FRAMEWORK (QOF) AND THE NHS HEALTH CHECK Author: CHARLOTTE SIMPSON, SPECIALTY REGISTAR PUBLIC HEALTH (ST3), CHESHIRE EAST COUNCIL/MERSEY DEANERY SUMMARY
More information